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thara R. Mohan, MD,† Saar Danon, MD,*† Daniel Levi, MD,* Dana Connolly, PHD,†
ohn W. Moore, MD, MPH*†
os Angeles and San Diego, California
bjectives Our aim was to determine key characteristics of stents commonly implanted in the
orta through bench testing and to describe our technique and acute results in patients weighing
30 kg.
ackground Despite the increasing use of stents for interventional treatment for coarctation of the
orta (CoA) in larger patients, use of large stents is controversial in small children.
ethods Methods included bench testing of large stents, and retrospective review of all patients
ver 1 year of age who had stent implantation for treatment of CoA. Patients were divided into 2
roups based on weight. Paired comparisons were made before and after stent implantation, and
roup outcomes were compared.
esults Sixty patients comprised the entire sample, with 22 patients assigned to group I (30 kg)
nd 38 patients assigned to group II (30 kg). The mean minimum diameters of the CoA (group I
.0 to 10.7 mm; group II 8.0 to 15.0 mm) and the ratio of the coarctation diameter to the descend-
ng aorta diameter measured at the level of the diaphragm (CoA/DAo ratio) (group I 0.4 to 0.93;
roup II 0.46 to 0.94) increased signiﬁcantly in both groups (all p  0.05). The mean systolic gradi-
nt decreased signiﬁcantly in both groups (group I 23.0 to 2.0 mm Hg; group II 24.0 to 2.8 mm Hg;
oth p  0.001). No difference was found between the groups in the CoA/DAo ratio, residual sys-
olic gradients, or the decrease in systolic gradient after stent implantation. There were no signiﬁ-
ant complications in patients under 30 kg.
onclusions As in larger patients, use of large stents for treatment of CoA in small children is effec-
ive and safe in the short term. In these patients, stent redilations will be required, and follow-up is
ngoing. (J Am Coll Cardiol Intv 2009;2:877–83) © 2009 by the American College of Cardiology
oundation
rom the *Mattel Children’s Hospital at UCLA, Los Angeles, California; and the †Rady Children’s Hospital and UCSD,
an Diego, California.anuscript received December 9, 2008; revised manuscript received May 15, 2009, accepted July 8, 2009.
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878atients with coarctation of the aorta (CoA) may present at
ny age, but most present in infancy or early childhood.
urgery is usually performed in infants presenting under 1
ear of age. After infancy, interventional techniques are
hosen over surgery because they are less invasive and result
n less procedure-related morbidity (1). Angioplasty is most
ften the treatment of choice in small children, whereas
tent implantation is usually preferred in older patients.
lthough reports of stent implantation in older patients
ith CoA demonstrate immediate results superior to
ngioplasty with fewer complications, angioplasty with-
ut stent implantation continues to be preferred in small
hildren (2– 6).
See page 884
We hypothesized that stent implantation is safe and effective
n all children over 1 year of age who undergo interventional
reatment of CoA. The objectives of this study are to deter-
ine key characteristics of stents commonly implanted in the
orta through bench testing and to describe our technique and
cute results in patients weighing 30 kg.
Methods
First, laboratory bench testing of
stents commonly used in larger
patients was performed. Then, a
retrospective review of pediatric
patients over 1 year of age who
underwent treatment of CoA in
the interventional catheterization
aboratory was conducted. We compared our results in small
hildren (30 kg) to our contemporaneous results in older
atients (30 kg).
aboratory testing. Laboratory testing of 2 stents com-
only used in patients 30 kg, Palmaz-Genesis (PG)
910B and PG1910B (Cordis Corp., Miami Lakes, Flor-
da) and ev3 IntraStent Mega LD (ev3 Inc., Plymouth,
innesota), was performed to determine the smallest
heath that could be used to implant these stents. The
aximum diameters and shortening characteristics of these
tents were determined to evaluate their redilation potential.
he stents were manually crimped onto balloon angioplasty
atheters with a minimum dilation diameter of 7 mm
Opta-Pro, Cordis Corp.). Attempts were made to push them
hrough sheaths (Cordis Corp.), beginning with the recom-
ended sheath for the balloon catheter alone (5-F). The
heath size was increased sequentially by 1-F size until it
ccommodated the balloon angioplasty catheter with mounted
tent. Subsequently, the stents were serially dilated using 10 to
2 mm diameter balloon angioplasty catheters and the stent
bbreviations and
cronyms
oA  coarctation of the
orta
oA/DAo ratio  the ratio of
he coarctation diameter to
he descending aorta
iameter measured at the
evel of the diaphragmiameters and lengths after each dilation were recorded. petrospective review. The clinical and catheterization data-
ases were reviewed to identify patients over 1 year of age,
ho had interventional treatment of CoA performed at
attel Children’s Hospital at UCLA between June 2003
nd June 2006 and at Rady Children’s Hospital, San Diego
etween July 2006 and July 2008. Patients who had aortic
oA after surgical aortic arch reconstruction, such as
ost-Norwood patients and patients with post-transplant
uture-line stenosis of the aorta were excluded. Stent pa-
ients were separated into 2 groups according to weight.
Clinical, catheterization, and angiographic data were studied
o determine patient characteristics, procedural technique and
haracteristics, results of procedure, and procedural complica-
ions. Outcome measures recorded pre- and post-procedure
ncluded minimum diameter at the coarctation site, the ratio of
he coarctation diameter to the descending aorta diameter
easured at the level of the diaphragm (CoA/DAo ratio), and
ystolic gradient across the coarctation.
tatistical methods. Statistical analysis was performed using
PSS version 16 for windows 2007 (SPSS Inc., Chicago,
llinois). Demographic, clinical, procedural, and hemody-
amic data were analyzed to describe the sample, and these
ata were examined for skewness and outliers. Descriptive
nd procedural data were compared between groups. Dif-
erences between groups’ pre- and post-intervention hemo-
ynamics and angiographic outcome measures were calcu-
ated using the paired t tests. Differences in outcome
easures between the 2 groups were then made using
ndependent samples t tests.
rocedural technique. Informed consent was obtained from
he patient or legal guardian. Catheterizations were per-
ormed under general anesthesia. Patients were heparinized
o maintain an activated clotting time 200 s. Arterial and
enous accesses were obtained, and standard right and left
eart catheterizations were performed. Hemodynamic eval-
ation included recording the gradient across the aortic arch
nd the CoA site. Angiography included aortograms in the
osteroanterior and lateral projections. The measurements
f the aorta were made from the angiograms including the
arrowest diameter and length of the coarctation, the
iameter of the transverse arch and the aorta at the
iaphragm. Stents were selected, positioned, and deployed
rom the femoral artery as described in previous reports
2–6). The short arterial sheaths were exchanged for long
heaths after positioning a stiff guidewire in the right
ubclavian artery or the ascending aorta. In group I, we were
uided by our bench testing and attempted to use the
mallest possible sheaths that would accommodate large
tents selected in part for redilation potential adequate to
ccommodate the patients’ growth. All stents were manually
rimped on high pressure balloons, inserted through the
heath, and positioned using angiography. After stent im-
lantation, hemodynamics and angiography were repeated.
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879atients were recovered and observed overnight in the
ospital. All patients were treated with low-dose aspirin.
esults
ench testing. The smallest sheath that accommodated the
G2910B stent was 6-F when it was mounted on a 7-mm
alloon angioplasty catheter (Figs. 1A and 1B). The 6-F
heath also accommodated an 8-mm diameter balloon,
hich allowed further dilation of the stent. Further dilations
f the PG2910B stent over 9-, 10-, and 12-mm balloons
ere achieved by upgrading the sheath size to 7-F.
The smallest sheath that accommodated the ev3 Mega
D stent was 8-F, when mounted on a balloon with an
nflation diameter of 12 mm (Figs. 1C and 1D). Further
Table 1. Laboratory Bench Testing Results
Balloon
Diameter, mm
Stent Diameter, mm Stent Length, mm
PG2910B ev3 Mega PG2910B ev3 Mega
Baseline 29 27
10 10 10 27 27–28
14 14 14 23 27
18 18 18 19 25–26
20 19 20 13 25
Figure 1. Bench Testing of ev3 and PG2910B Stents
(A) PG2910B stent crimped over balloon catheter; (B) stent balloon system be
and (D) stent balloon system being introduced through the 8-F sheath.22 19 22 12.5 23ilation of the stent using a 14-mm balloon was successfully
erformed through the 8-F sheath.
Results of serial dilations of the PG2910B and the ev3
ega LD stents appear in Table 1. The maximum diameter
Figure 2. ev3 and PG2910B Stents at Maximal Expansion
The open cell structure of the ev3 stent helps maintain its length (23 mm)
and allows it to achieve larger diameter (22 mm), as compared with the
shortening (12.5 mm) of the PG2910B stent with lesser diameter (19 mm)
roduced through 6-F sheath; (C) ev3 stent crimped over balloon catheter;ing intseen on maximal expansion.
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880chieved for the PG stent was 19 mm, and for the ev3 stent
as 22 mm, using a 22-mm balloon angioplasty catheter,
hown in Figure 2. The initial lengths for the PG and ev3
tents were 29 mm and 27 mm, respectively. Final lengths
ere 13 mm for the PG (45% of the initial length) and 23
m for the ev3 (85% of the initial length). However, when
Table 2. Descriptive Data of Patients in Both Groups (n  60)
Group I Group II
Mean age (yrs) 5.6 4.0 17.1 5.9
Mean weight (kg) 19.8 5.3 56.9 17.5
CoA diameter (mm)
Pre 5 1.9 8 2.7
Post 10.7 2.3 15 2.16
CoA/DAo ratio
Pre 0.4 0.17 0.46 0.16
Post 0.93 0.16 0.94 0.12
Mean gradient (mm Hg)
Pre 23 0.3 24 18
Post 2 3.1 2.8 4.5
CoA/DAo ratio  the ratio of the coarctation diameter to the descending aorta diameter mea-
sured at the level of the diaphragm; CoA Pre  diameter at coarctation site before stent; CoA
Post  diameter of CoA after stent; Mean gradient Pre  mean systolic gradient before stent;
Mean gradient Postmean systolic gradient after stent.
Table 3. Demographics, Sheath, Stent, and Balloon Sizes Used in
Patients Under 30 kg
Patient
# Gender
Weight,
kg
Age,
yrs
Sheath,
F Stent
Max Balloon,
mm
1 F 9.7 1 6 PG2910B 7
2 F 12.2 2.8 6 PG1910B 8
3 M 13.6 2.6 7 PG2910B 10
4 M 14.5 4.4 6 PG2910B 8
5 M 14.5 4.5 6 PG1910B 7
6 M 14.8 2.5 6 PG1910B 8
7 M 15 3.3 7 PG1910B 12
8 M 17 4.5 8 PG1910B 10
9 M 17.5 5.7 8 ev3 12
10 M 20 4 8 PG1910B 12
11 F 20.4 5.0 7 PG1910B 10
12 M 21 9.4 7 PG2910B 10
13 M 21.8 9.9 9 PG2910B 12
14 M 21.9 5 8 ev3 14
15 M 22.2 6.7 9 PG2910B 12
16 M 23.5 8 8 PG2910B 12
17 M 24.5 7 10 ev3 12
18 M 25 6.1 9 PG2910B 12
19 M 25.7 10 10 ev3 14
20 M 27 3.7 7 PG1910B 12
21 M 27 8.0 8 ev3 12
22 F 27 9.3 9 ev3 12
Sheath  size of sheath used; Stent  type of stent used; Max Balloon  maximum ballooniinflation diameter for stent placement.he PG stent was expanded to 18 mm, the length only
hortened to 19 mm (66% of the initial length).
etrospective review of patient records. Sixty-three patients
ver 1 year of age underwent interventional treatment of
imple CoA. Three parents selected angioplasty rather than
tent implantation for their children, and thus were ex-
luded. Therefore, 60 patients comprised the clinical por-
ion of the study sample. Patients who weighed less than 30
g were assigned to group I (n  22) and those who
eighed 30 kg comprised group II (n  38). The sample
haracteristics are summarized in Table 2.
ROUP I. Mean patient age was 5.6 years and mean
eight was 19.8 kg. Eleven patients had native COA
nd 11 had recurrent COA. Of the patients with recur-
ent CoA, 6 were post-surgery and 5 post-balloon angio-
lasty. Detailed descriptive and procedural data for
roup I patients (30 kg) are displayed in Tables 3 and
. Figure 3 shows the representative angiograms (Patient
9 reported in Tables 3 and 4) before and after stent
Table 4. Hemodynamic Results in Patients Under 30 kg (Group I, n  22)
Patient
#
DAo,
mm
Gradient
Pre,
mm Hg
Gradient
Post,
mm Hg
Pre-CoA,
mm
Pre-CoA/
DAo
Post-CoA,
mm
Post-CoA/
DAo
1 7.1 16 8 3.3 0.5 7 1
2 8 22 8 3 0.4 7.3 0.9
3 10 21 0 4.5 0.5 10 1.1
4 8 22 2 4.2 0.6 8 1.1
5 9.2 40 0 1.3 0.1 7 0.8
6 14 10 1 5 0.35 8 0.6
7 14.4 17 0 5.5 0.4 12 0.8
8 12.7 25 8 5.7 0.45 10 0.8
9 12 24 0 4 0.3 12 1.0
10 10 15 2 6.2 0.62 9.5 0.95
11 10 10 0 7.5 0.8 10 1.1
12 12 27 9 4.9 0.4 12 1.0
13 15.5 49 1 2 0.1 11 0.7
14 16.4 20 4 8.3 0.5 14 0.85
15 11.2 23 1 5.3 0.5 10 0.9
16 16.5 38 0 5.2 0.54 10 0.97
17 13 37 0 3 0.23 12 0.92
18 13.5 21 0 4 0.3 12 0.9
19 21 15 2 6.8 0.32 14 0.7
20 12.5 12 0 6.1 0.5 12 1.0
21 12 26 0 8 0.7 12 1.1
22 12 11 0 6.7 0.6 12 1.3
DAo  diameter of aorta at the level of the diaphragm; Gradient Post  systolic gradient after
stent placement; Gradient Pre systolic gradient before stent placement; Post-CoAminimal
diameter at the coarctation site after stent placement; Post-CoA/DAo ratio of the coarctation
diameter to the descending aorta diameter measured at the level of the diaphragm after stent
placement; Pre-CoAminimal diameter at the coarctation site before stent placement; Pre-CoA/
DAo ratio of the coarctation diameter to the descending aorta diameter measured at the level
of the diaphragm before stent.mplantation.
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881Types of stents used are reported in Figure 4. Final
atient sheath sizes ranged from 6- to 10-F. Final balloon
iameters ranged from 7 mm to 14 mm. Stents were either
rom the PG series or the ev3 Mega LD series. Sheaths of
-F accommodated PG stents with final balloon diameters
f 7 or 8 mm in 5 of the 6 smallest patients.
The mean minimum CoA diameter increased signifi-
antly from 5  1.9 mm pre-procedure to 10.7  2.3 mm
ost-stent angioplasty (p  0.001). The CoA/DAo ratio
lso increased significantly from 0.4  0.17 to 0.93  0.16
p  0.001). Pre-stent systolic gradients ranged from 10 to
0 mm Hg, with a mean of 23  10.3. Post-stent systolic
radients decreased significantly ranging from 0 to 9 mm
g, with a mean of 2.0  3.1 mm Hg (p  0.001).
ROUP II. Patients ranged in age from 6.6 to 41.7 years,
ith a mean age of 17.1  5.9 years. Weights ranged from
0.9 to 94.4 kg, with a mean of 57  17.5 kg. Twenty-two
ad native CoA and 16 had recurrent CoA. Nine were
ost-surgery and 7 were post-balloon angioplasty. The
Figure 3. Angiograms Before and After Stent Placement in Patient #9
(A and B) Anteroposterior and lateral aortic angiography demonstrating native
phy after stent angioplasty with ev3 Mega LD stent, deployed with 12-mm Coean minimum CoA diameter increased significantly from L 2.7 mm pre-procedure to 15  2.16 mm post-stent
ngioplasty (p  0.001). In group II, the CoA/DAo ratio
lso increased significantly from 0.46 0.16 to 0.94 0.12
p  0.036). Pre-stent systolic gradients ranged from 7 to
4 mm Hg, with a mean of 24  18 mm Hg. Post-stent
ystolic gradients decreased significantly ranging from 0 to
9 mm Hg, with a mean of 2.8  4.5 mm Hg (p  0.001).
roup comparisons. Patients in both groups had significant
aired increases in coarctation diameters and in the CoA/
Ao ratio as well as decreases in gradients across the area of
oA post-stent implantation. When these results were
ompared between the 2 groups, group II patients (30 kg)
ad significantly greater diameter increase (p  0.006) and
oA/DAo ratio increase (p  0.001). No significant dif-
erences were found between patients under and over 30 kg
n post-stent CoA/DAo ratio, residual mean systolic gradi-
nts, or decrease in mean systolic gradients post-procedure.
omplications. No complications were reported in group I
atients. Complications were seen in 3 group II patients.
ctation in a 5-year-old, 17.5-kg patient. (C and D) Post-intervention angiogra-
pta Pro balloon angioplasty catheter using 8-F femoral arterial access.coaross of femoral pulse was seen in 2 patients, which resolved
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882ithin 24 h with intravenous heparin therapy. One patient
ad formed a small aortic aneurysm at the site of previous
alloon angioplasty. He developed aortic dissection after
tent implantation. Twelve Gianturco coils (Cook Inc.,
loomington, Indiana) were placed through the side of the
tent to close the aneurysm and limit further aortic dissec-
ion. The alternative option was to place a covered stent
cross the dissection, which would have been the treatment
f choice had one readily been available.
iscussion
he results of this study demonstrate the safety and efficacy
f immediate results of stent implantation to correct CoA in
mall children. No difference was found between patients
nder and over 30 kg in post-stent CoA/DAo ratio, residual
ystolic gradient, or decrease in systolic gradient post-
rocedure. The stents we implanted in the patients under 30
g have the potential for redilation to diameters that can
ccommodate somatic growth through adulthood. More-
ver, our results of stent implantation in both groups are
imilar to those that have been previously reported in sample
opulations of larger patients (7–10).
Although balloon angioplasty without stent implantation
ontinues to be advocated as the initial treatment of CoA in
mall children (2), the results of angioplasty have been
uboptimal because of residual gradients and stenoses. Most
nstitutions define procedural success as a residual gradient
ess than 20 mm Hg and report average residual gradients
etween 6.2  5.9 mm Hg and 16  15 mm Hg.
2,4,5,11–14). In perhaps the most extensive review of
ngioplasty procedures, McCrindle et al. (6) evaluated data
Figure 4. Type of Stents Used in Group I Patients
X axis denotes the stents used: ev3, PG1910B, and PG2910B stents. Y axis
shows the total number of patients who had each type of stent placed.rom 970 angioplasties at 25 centers from 1982 to 1995. vedian residual gradient after angioplasty was 9 mm, and a
esidual systolic gradient of 20 mm was observed in 19%
f native and 25% of recurrent CoAs. Angioplasty reports to
ate have set the standard for success at a level that
ssentially justifies persistent residual CoA in a high per-
entage of patients. In our series, the median residual
ystolic gradients observed in both groups were 0.5 mm Hg.
Complications after angioplasty alone may be greater
han after stent implantation. The risk of aneurysm forma-
ion after balloon angioplasty has been reported in up to
0% of cases (4,14,15). In contrast, stent implantation has
ad a lesser risk of aneurysm formation (8,16,17). In a study
omparing stent placement versus balloon angioplasty in
dolescents and adults with CoA, Pedra et al. (13) reported
lower risk of aortic wall abnormalities in stented patients.
n their study, of the 15 patients who underwent balloon
ngioplasty, 8 had wall abnormalities, consisting of 2
issections, 4 irregularities, and 2 aneurysms. In contrast,
hey found only 1 of 21 stent patients developed an
neurysm. In our series, no wall abnormalities were observed
mong 22 patients under 30 kg, and only 1 abnormality was
bserved in the larger patients.
To date, there is no longitudinal evidence supporting
ong-term benefit of stent implantation in young patients.
owever, there are surgical data suggesting that younger
atients who experience relief of aortic obstruction have a
ower incidence of residual hypertension and morbidities
han do patients who achieve relief at older ages. Heger
t al. (18) demonstrated vascular dysfunction to be more
ersistent in patients operated after 9 than among those
perated before 9 years of age. In another study, Toro-
alazar et al. (19), in their analysis of 254 patients operated
etween 1948 and 1976, reported operative mortality in 7%
f their study sample, persistent hypertension in 30% (after
0 years) to 46% (after 50 years), with best survival results in
atients having had surgery under 5 years of age. Therefore,
uch long-term trends may be seen in patients who have
heir CoA treated early and effectively in the interventional
atheterization laboratory.
The principle disadvantage of stent implantation in
oung children is the need for stent redilation to accommo-
ate growth. As demonstrated by our bench studies, we
elieve that in most of our patients the stents we implanted
ave adequate redilation potential to achieve adult aortic
imensions. The feasibility of in vivo redilation has been
onfirmed by both animal studies (19), and clinical data in
lder children and adults (9,16,20–22). Morrow et al. (23)
emonstrated the feasibility of re-expansion of the stents in
he aorta of swine, without significant injury to the neoin-
ima, the media, or the adventitia.
There are limited previous reports of stent implantation
or primary treatment of CoA in small children. Golden and
ellenbrand (2), in their review of the Congenital Cardio-
ascular Interventional Study Consortium data consisting of
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88388 stent placements for CoA in children and adults from
7 centers, report only 7% (40 of 588) of the patients were
nder 6 years of age. Schaeffler et al. (24) reported 9 patients
ith a median weight of 14 kg (range 5.5 to 19 kg) who
nderwent successful stent placement for CoA. In our
tudy, we report 22 patients with a median weight of 20.7 kg
range 9.7 to 27 kg). Thirty-seven percent of the patients
22 of 60) were under 30 kg and had successful implantation
f large stents.
This is the first report describing excellent acute out-
omes and low risk among a group of small children with
oA who were consistently treated by stent implantation.
id- and long-term outcomes of stent implantation in
mall children with CoA are needed. Stent redilations and
ata collection through follow-up evaluations are ongoing.
eprint requests and correspondence: Dr. John W. Moore, Section
f Pediatric Cardiology, UCSD, Rady Children’s Hospital–San
iego, 3020 Children’s Way, MC 5004, San Diego, California
2123. E-mail: jmoore@rchsd.org.
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